Avacta appoints Chief Scientific Officer Dr. Michelle Morrow has been appointed as Chief Scientific Officer of Avacta Group plc, effective November 4, 2024. With nearly…
Avacta Group – Exploring NASDAQ Dual-Listing And Divesting Its Diagnostics Division, Analyst Has 188p Valuation, Shares Now 45.5p On Wednesday 30th October, Avacta Group (LON:AVCT), the cancer treatments and diagnostics life sciences business, will be presenting a live…
Avacta Group elects to settle convertible bond payment in cash Avacta Group has announced its decision to settle the upcoming July quarterly amortisation payment for its unsecured convertible bonds in…